Amgen reports Q1 adjusted EPS $3.96, consensus $3.87 Reports Q1 revenue $7.4B, consensus $7.44B. "With many of our innovative products delivering strong growth and promising new medicines advancing through our pipeline, we are excited about delivering attractive long-term growth," said Robert Bradway, chairman and CEO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.